[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350282-105":59,"doc-detail-350282-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prostate-cancer-genetic-susceptibility-and-risk-of-chronic-non-urological-complications","Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications","","Chronic nonurological complications are prevalent among prostate cancer (PCa) survivors, yet their full range, effect size, and genetic underpinnings remain insufficiently mapped. Using 15 nonurological complications, PCa exposure, and disease-specific polygenic risk scores in UK Biobank (N=219,133), cause-specific Cox models assessed associations with time-updated PCa status. After recruitment, PCa related to higher risks of seven complications, with stronger effects for metastatic PCa and further escalation across higher PCa-specific PRS.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prostate-cancer-genetic-susceptibility-and-risk-of-chronic-non-urological-complications/350282/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prostate-cancer-genetic-susceptibility-and-risk-of-chronic-non-urological-complications/350282.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study?","Question",{"text":113,"@type":114},"To characterize the spectrum and magnitude of chronic nonurological complications among prostate cancer survivors and evaluate how genetic susceptibility contributes to these risks.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were associations between prostate cancer and complications analyzed?",{"text":118,"@type":114},"The study tested links between PCa exposure and disease-specific polygenic risk scores using cause-specific Cox proportional-hazards models with time-updated PCa status in a full-cohort framework.",{"name":120,"@type":111,"acceptedAnswer":121},"Which complications showed higher risks after prostate cancer diagnosis?",{"text":122,"@type":114},"Risks for osteoporosis, venous thromboembolism, depression, and four primary cancers (bladder, kidney, colorectal, and pancreatic) were higher among men with PCa after adjusting for genetic background.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350282,1790489686,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","The Prostate   \nORIGINAL ARTICLE   \nProstate Cancer, Genetic Susceptibility, and Risk of Chronic Non‐Urological Complications  \nBrian T. Helfand1,2,3 | Zhuqing Shi2 | Ashley J. Mulford4 | Huy Tran2 | Jun Wei2 | Annabelle Ashworth2 | S. Lilly Zheng2 | Alan R. Sanders3,4 | Nathan Graham3 | Joshua Cabral3  | Jim Lu5 | Jennifer L. Beebe‐Dimmer6 | Kathleen A. Cooney7 | David Duggan8 | Jianfeng Xu1,2,3   \n1Division of Urology, Endeavor Health, Evanston, Illinois, USA | 2Program for Genomic Translational Research, Endeavor Health, Evanston, Illinois, USA | 3Section of Urology, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA | 4Genomic Health Initiative, Endeavor Health, Evanston, Illinois, USA | 5GoPath Diagnostics, Buffalo Grove, Illinois, USA | 6Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA | 7Department of Medicine and the Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA | 8Translational Genomics Research Institute, Part of City of Hope, Phoenix, Arizona, USA  \nCorrespondence: Jianfeng Xu ([jianfeng.xu@endeavorhealth.org](jianfeng.xu@endeavorhealth.org))  \nReceived: 20 February 2026 | Revised: 31 March 2026 | Accepted: 16 April 2026  \nKeywords: cardiovascular disease | chronic obstructive pulmonary disease | comorbidities | complications | depression | osteoporosis | secondary primary cancers | venous thromboembolism  \nABSTRACT  \nBackground: Chronic nonurological complications are common among prostate cancer (PCa) survivors; however, their spectrum, magnitude, and genetic contribution remain poorly characterized.  \nMethods: We evaluated 15 commonly reported nonurological complications and tested their associations with exposure to PCa and disease‐specific polygenic risk scores (PRS) in the UK Biobank (UKB; N = 219,133) . Analyses were conducted using cause‐ specific Cox proportional‐hazards models within a full‐cohort framework with time‐updated PCa status, delayed entry at study recruitment, and age as the underlying time scale.  \nResults: After recruitment, incident PCa was diagnosed in 13,780 men, of which 1,656 (12.02%) had metastatic PCa (mPCa) . Risks for seven complications were higher among men with PCa, adjusting for genetic background (all p \u003C 0.05), including osteoporosis, venous thromboembolism, depression, and four primary cancers (bladder, kidney, colorectal, and pancreatic) . Risks were consistently stronger among men exposed to mPCa than non‐mPCa; for example, the hazard ratio (HR) (95% confidence interval) for osteoporosis was 1.88 (1.63–2.18) for any PCa, 4.67 (3.11–7.01) for mPCa, and 1.75 (1.50–2.04) for non‐ mPCa. Elevated risks for three additional complications (coronary artery disease, type 2 diabetes and chronic obstructive pulmonary disease) were observed only among men with mPCa. The risks for these ten complications were further increased among men with higher disease‐specific PRS; for example, the HR for osteoperosis in mPCa patients in the top PRS quartile was 13.57 (8.24–22.34) compared with men without PCa (p \u003C 0.001) .  \nConclusion: PCa diagnosis and inherited genetic susceptibility jointly contribute to increased risks of multiple chronic non‐ urological complications among survivors.  \n1 | Introduction  \nWith earlier diagnosis and more effective treatment, many men with prostate cancer (PCa) now live long after their initial  \ndiagnosis, resulting in an estimated > 3.5 million PCa survivors in the United States by 2025 [1] . However, survivorship is often complicated by long‐term adverse health conditions related to the cancer itself or its treatments [2, 3] . These sequelae can  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.  \n© 2026","cbCaitTXwbb67cYs","https://ap.wps.com/l/cbCaitTXwbb67cYs","pdf",1203533,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To characterize the spectrum and magnitude of chronic nonurological complications among prostate cancer survivors and evaluate how genetic susceptibility contributes to these risks.\"},{\"question\":\"How were associations between prostate cancer and complications analyzed?\",\"answer\":\"The study tested links between PCa exposure and disease-specific polygenic risk scores using cause-specific Cox proportional-hazards models with time-updated PCa status in a full-cohort framework.\"},{\"question\":\"Which complications showed higher risks after prostate cancer diagnosis?\",\"answer\":\"Risks for osteoporosis, venous thromboembolism, depression, and four primary cancers (bladder, kidney, colorectal, and pancreatic) were higher among men with PCa after adjusting for genetic background.\"}]","Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications | PDF",1790088208,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc4b32a31b880fe4d3424a9c7aa67c99.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df21bd7b9437616c6e4dcc351f9aeff9.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/455edd2b4f839b60d526c3f93e69b700.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24448bc66c1164a7572b98b4dea9a0be.webp",980,1287]